SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Long-term results of a phase II study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma

    Salar A (1), Domingo-Domenech E (2), Panizo C (3), Nicolás C (4), Bargay J (5), Muntañola A (6), Canales M (7), Bello JL (8), Sancho JM (9), Tomás JF (10), Rodríguez MJ (11), Peñalver J (12), Grande C (13), Sánchez-Blanco JJ (14), Palomera L (15), Arranz R (16), Conde E (17), García M (18), García JF (19), Caballero D (20), Montalbán C (10). (1) Department of Hematology, Hospital del Mar, Barcelona, Spain.
    (2) Department of Hematology, Hospital Durans i Reynals, Barcelona, Spain.
    (3) Department of Hematology, Clinica Universitaria de Navarra, Pamplona, Spain.
    (4) Department of Hematology, Hospital Central de Asturias, Asturias, Spain.
    (5) Department of Hematology, Hospital Son Llatzer, Mallorca, Spain.
    (6) Department of Hematology, Hospital Universitario Mutua de Terrassa, Terrassa, Spain.
    (7) Department of Hematology, Hospital Universitario La Paz, Madrid, Spain.
    (8) Department of Hematology, Complejo Universitario de Santiago, Santiago de Compostela, Spain.
    (9) Department of Hematology, Hospital Germans Trias i Pujol, Badalona, Spain.
    (10) Department of Hematology, MD Anderson Cancer Center, Madrid, Spain.
    (11) Department of Hematology, Hospital Universitario de Canarias, Tenerife, Spain.
    (12) Department of Hematology, Hospital Fundacion Alcorcon, Alcorcon, Spain.
    (13) Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
    (14) Department of Hematology, Hospital Morales Meseguer, Murcia, Spain.
    (15) Department of Hematology, Hospital Clinico Lozano Blesa, Zaragoza, Spain.
    (16) Department of Hematology, Hospital Universitario La Princesa, Madrid, Spain.
    (17) Department of Hematology, Hospital Marques de Valdecilla, Santander, Spain.
    (18) Department of Anatomic Pathology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
    (19) Department of Anatomic Pathology, MD Anderson Cancer Center, Madrid, Spain.
    (20) Department of Hematology, Hospital Clinico de Salamanca, Salamanca, Spain.

    Blood 11 AUGUST 2017

  • Characterization of Surgical Procedures in the Spanish Mohs Surgery Registry (REGESMOHS) for 2013-2015

    de Eusebio Murillo E (1), Martín Fuentes A (2), Ruiz-Salas V (3), Garcés JR (4), Miñano Medrano R (5), López-Estebaranz JL (5), Alonso-Alonso T (6), Rodríguez-Prieto MÁ (6), Delgado Jiménez Y (7), Morales V (8), Redondo Bellón P (9), Manubens-Mercadé E (10), Sanmartín-Jiménez O 11, Guillén Barona C (11), Cabeza R (12), Cano N (12), Toll-Abelló A (13), Navarro Tejedor R (14), Artola Igarza JL (15), Allende Markixana I (16), Alfaro Rubio A (17), Ciudad Blanco C (18), Vázquez-Veiga H (19), Barchino Ortiz L (20), Descalzo MA (21), García-Doval I (21). (1) Hospital Universitario de Guadalajara, Guadalajara, España.
    (2) Hospital Universitario de Guadalajara, Guadalajara, España.
    (3) Hospital de la Santa Creu i Sant Pau, Barcelona, España.
    (4) Hospital de la Santa Creu i Sant Pau, Barcelona, España; Hospital Quirón Teknon, Barcelona, España.
    (5) Hospital Universitario Fundación Alcorcón, Madrid, España.
    (6) Complejo Asistencial Universitario de León, León, España.
    (7) Clínica Quirón, Madrid, España; Hospital de la Princesa, Madrid, España.
    (8) Clínica Quirón, Madrid, España.
    (9) Clínica Universitaria de Navarra, Pamplona, España.
    (10) Hospital Quirón Teknon, Barcelona, España.
    (11) Instituto Valenciano de Oncología, Valencia, España.
    (12) Hospital La Zarzuela, Madrid, España.
    (13) Hospital del Mar, Barcelona, España.
    (14) Hospital de la Princesa, Madrid, España.
    (15) Hospital Galdakao, Bizkaia, España.
    (16) Hospital Universitario de Cruces, Barakaldo, España.
    (17) Hospital de Manises, Valencia, España.
    (18) Hospital Gregorio Marañón, Madrid, España.
    (19) Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, España.
    (20) Hospital La Zarzuela, Madrid, España; Hospital Gregorio Marañón, Madrid, España.
    (21) Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología, Madrid, España.

    Actas Dermosifiliográficas 09 AUGUST 2017

  • Improving the gamma analysis comparison using an unbinned multivariate test

    Ramos Garcia LI (1), Perez Azorin JF (2), Aguilar-Redondo PB (3), Moran-Velasco V (3). (1) Department of Medical Physics, Clinica Universidad de Navarra, Pamplona, Navarra, SPAIN.
    (2) MEDICAL PHYSICS, UNIVERSITY HOSPITAL OF CRUCES, PLAZA DE CRUCES s/n, BARAKALDO, BIZKAIA, SPAIN.
    (3) Oncologia, Clinica Universidad de Navarra, Pamplona, Navarra, SPAIN.

    Physics in Medicine and Biology 08 AUGUST 2017

  • Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity

    A-Cienfuegos J (1), Rotellar F (2), Ruiz-Canela M (3). (1) Cirugía/ Apoyo Investigación, Clinica Universidad de Navarra, España.
    (2) Cirugía General y Digestiva, Clinica Universidad de Navarra, España.
    (3) Department of Preventive Medicine and Public Healt, Medical School. University of Navarra, España.

    Revista Española de Enfermedades Digestivas 04 AUGUST 2017

  • The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma

    Macias RIR (1), Banales JM (2), Sangro B (3), Muntané J (4), Avila MA (5), Lozano E (6), Perugorria MJ (2), Padillo FJ (4), Bujanda L (7), Marin JJG (6). (1) Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, Salamanca, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
    (2) Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
    (3) Liver Unit, Clínica Universidad de Navarra, IDISNA, Pamplona, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
    (4) Department of General Surgery, "Virgen del Rocío" University Hospital, IBiS/CSIC/University of Sevilla, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
    (5) Division of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, Pamplona, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
    (6) Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, Salamanca, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
    (7) Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.

    Biochimica et Biophysica Acta 04 AUGUST 2017

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra